Overview of Business Development at Ligand
Business development is at the heart of the Ligand business model. In order to build the large portfolio of partnered assets that drives our revenue model, we are constantly focused on licensing out assets to new partners or bringing in assets and technologies that can create new deals. Partnering allows us to get our assets into the hands of companies who have the development, regulatory, and commercial expertise to get those drugs to patients in need; all while keeping our cost structure low.
Ligand currently has multiple internal programs that are available for licensing. We also offer our Captisol formulation technology to partners who have internal programs where Captisol may aid in formulation.
Site 'Main' Navigation: